Center for Genetic Engineering and Biotechnology (CIGB)
Cuba’s Soberana 02 vaccine shows 91.2% efficacy against COVID-19

With the historic achievement, two out of the five Cuban vaccine candidates, Soberana 02 with 91.2% and Abdala with 92.28% efficacy, are among the top 5 most effective anti-COVID-19 vaccines worldwide

Cuba’s journey of developing vaccines while battling US blockade

Two new vaccines, both developed in Cuba, have shown remarkable efficacy in clinical trials. It is crucial to remember that Cuba developed these vaccines even as it continues to suffer under the crippling blockade imposed by the US.

Cuba’s Abdala and Soberana 02 vaccines near the finish line

The Abdala vaccine showed 92.28% efficacy with three doses during the third phase of clinical trials and the Soberana 02 vaccine showed 62% efficacy with just two of its three doses

    × To Subscribe